Clinical Trial

Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer

Completed
View on ClinicalTrials.gov →
Summary
The aim of the study is 1. Statistical evaluation of patients' characteristics who have intermediate \& high risk localized prostate cancer. 2. Statistical analysis of treatment efficacy of combined hormonal therapy \& hypo fractionated intensity modulated radiotherapy compared with conventionally fractionated radiotherapy plus hormonal treatment as regard biochemical failure, disease free survival \& overall survival. 3. Evaluation of acute as well as late toxic side effects after radiotherapy.
Trial Details
NCT Number NCT07489729
Lead Sponsor Tanta University
Conditions Hypofractionated Dose, Prostate Cancer Patients
Enrollment 60 participants
Start Date 2022-06-30
Primary Completion 2024-06-30 (estimated)
Study Completion 2024-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-24